Boston Trust Walden’s Boston Scientific BSX Stock Holding History

Boston Trust Walden’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$332K	Hold	7,768	–	–	﹤0.01%	362
2026 Q1	$487K	Hold	7,768	–	–	﹤0.01%	327
2025 Q4	$741K	Sell	7,768 -25	-0.3%	-$2.45K	0.01%	299
2025 Q3	$761K	Sell	7,793 -25,874	-77%	-$2.68M	0.01%	300
2025 Q2	$3.62M	Buy	33,667 +27,011	+406%	+$2.73M	0.03%	233
2025 Q1	$671K	Sell	6,656 -3,275	-33%	-$330K	﹤0.01%	302
2024 Q4	$887K	Sell	9,931 -1,250	-11%	-$110K	0.01%	287
2024 Q3	$937K	Hold	11,181	–	–	0.01%	286
2024 Q2	$861K	Hold	11,181	–	–	0.01%	284
2024 Q1	$766K	Hold	11,181	–	–	0.01%	292
2023 Q4	$646K	Hold	11,181	–	–	﹤0.01%	303
2023 Q3	$590K	Hold	11,181	–	–	﹤0.01%	302
2023 Q2	$605K	Hold	11,181	–	–	0.01%	300
2023 Q1	$559K	Hold	11,181	–	–	﹤0.01%	304
2022 Q4	$517K	Hold	11,181	–	–	﹤0.01%	308
2022 Q3	$433K	Hold	11,181	–	–	﹤0.01%	309
2022 Q2	$417K	Buy	11,181 +31	+0.3%	+$1.26K	﹤0.01%	311
2022 Q1	$494K	Hold	11,150	–	–	﹤0.01%	318
2021 Q4	$474K	Buy	11,150 +1,000	+10%	+$42K	﹤0.01%	332
2021 Q3	$440K	Hold	10,150	–	–	﹤0.01%	331
2021 Q2	$434K	Hold	10,150	–	–	﹤0.01%	336
2021 Q1	$392K	Sell	10,150 -1,852	-15%	-$70.1K	﹤0.01%	330
2020 Q4	$431K	Hold	12,002	–	–	﹤0.01%	326
2020 Q3	$459K	Sell	12,002 -147	-1%	-$5.67K	0.01%	316
2020 Q2	$427K	Hold	12,149	–	–	0.01%	323
2020 Q1	$396K	Sell	12,149 -2,600	-18%	-$102K	0.01%	315
2019 Q4	$667K	Sell	14,749 -353	-2%	-$14.8K	0.01%	311
2019 Q3	$615K	Buy	15,102 +3,100	+26%	+$131K	0.01%	311
2019 Q2	$516K	Hold	12,002	–	–	0.01%	324
2019 Q1	$461K	Hold	12,002	–	–	0.01%	335
2018 Q4	$424K	Hold	12,002	–	–	0.01%	331
2018 Q3	$462K	Hold	12,002	–	–	0.01%	336
2018 Q2	$392K	Hold	12,002	–	–	0.01%	345
2018 Q1	$328K	Hold	12,002	–	–	0.01%	358
2017 Q4	$298K	Hold	12,002	–	–	﹤0.01%	358
2017 Q3	$350K	Hold	12,002	–	–	0.01%	350
2017 Q2	$333K	Buy	+12,002	New	+$319K	0.01%	349

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Milford Funds Auckland $6.14B AUM

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Banque Transatlantique Paris, France $4.66B AUM 33.26% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Boston Trust Walden's BSX Position: Q2 2026 in Review

Boston Trust Walden held its Boston Scientific (BSX) position steady in Q2 2026 at 7,768 shares worth $332K. The position accounts for ﹤0.01% of the portfolio, ranked #362.

Boston Trust Walden first reported a position in BSX in Q2 2017 and has held it in 37 quarters since. The position peaked at $3.62M in Q2 2025. 495 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Boston Trust Walden held 7,768 shares of Boston Scientific worth $332K as of Q2 2026.
Boston Trust Walden left its Boston Scientific share count unchanged in Q2 2026.
Boston Scientific made up ﹤0.01% of Boston Trust Walden's portfolio in Q2 2026, its #362 holding.
Boston Trust Walden first reported a position in Boston Scientific in Q2 2017 and has held it in 37 quarters since.
Boston Trust Walden's Boston Scientific position peaked at $3.62M in Q2 2025.
495 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.